Upstate Active Clinical Trials Seeking Participants
Study title
Autologous Hematopoietic Stem Cell and/or Bone Marrow Transplantation after High Dose Chemotherapy (Carboplatinum, Etoposide) in Patients with Recurrent/Refractory Germ Cell Tumors
IRB number
3260
What is the purpose of the study?
To provide autologous transplantation for patients with Germ Cell Tumors.
Who is eligible?
Diagnosis of Germ Cell Tumors, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.
What is involved if I participate?
- How long is the study?
Inpatient stay approximately 21 days, followed for lifetime. - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.
Who is the doctor administering the study?
Teresa C. Gentile, M.D. Ph.D.
Where will the study take place?
SUNY Upstate Medical University,
Syracuse, NY
Over what time period is the study scheduled to run?
1/96 (continuing)
Who can I contact for more information?
- Name: Joanne M Chilton, CCRP
- Phone: (315) 464-8240
- Email: chiltonj@upstate.edu
- Fax: (315) 464-8247 or (315) 464-8289
If you are interested in this trial, please contact the study coordinator or investigator noted above.
